Hello, everyone, and welcome to another busy day. This may be the sleepy stretch of summer, but the world is spinning as quickly as ever, yes? And so we must prepare for still more deadlines and meetings. As you do the same, here are a few tidbits to help you along. So grab a cup of something stimulating and dig in. Have a good one and stay in touch...
Allergan CEO Says Company Is Not For Sale (Dow Jones)
Sanofi Shareholders Want Genzyme For $19 Billion (Reuters)
Alcon Shareholders Told To Vote No On Novartis Slate (PharmaTimes)
FDA Guidance Aims To Cut Residual Drug In Patches (InPharma Technologist)
Will Botox Be Approved For Migraines? (Reuters)
Diabetes Drugs Dispensed In UK Zooms By 43% (PharmaTimes)
AstraZeneca VAT Voucher Case Rings Alarm Bells (Accountancy Age)
KV Pharma Gets NYSE Delisting Warning (St. Louis Business Journal)